French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival ...

Prolific local psych act Carlton Melton plays an increasingly rare San Francisco show this Saturday at the Kilowatt in the ...

As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and ...

France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...

Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after ...

The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...

Sanofi has chosen US private equity firm Clayton, Dubilier & Rice to advance acquisition talks for its consumer health unit, ...

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

Potential deal by Clayton Dubilier & Rice for a leading consumer healthcare business; Arlington Capital Partners’ Matthew ...

Sanofi is nearing the sale of its consumer health business to Clayton Dubilier & Rice, a year after Chief Executive Officer Paul Hudson announced plans to split off the division to concentrate on ...